Chemicals · Founded 1956 · http://www.elantas.com/beck-india · BSE 500123 · NSE ELANTAS · ISIN INE280B01018
No Notes Added Yet
Business
Elantas Beck India Ltd. is a specialty chemicals company primarily engaged in the manufacturing and sale of electrical insulation materials and other industrial coatings. As a part of the German specialty chemicals group ALTANA AG, the company leverages global technology and R&D. Its core business model revolves around developing, producing, and supplying high-performance solutions crucial for the electrical and electronics industries. The company makes money by selling products like wire enamels, impregnating resins, varnishes, and compounds used in applications such as electric motors, transformers, generators, home appliances, and automotive components.
Revenue Mix
The company's primary business segment is Electrical Insulation Materials. This segment includes wire enamels for winding wires and various impregnating resins, varnishes, and casting compounds used for insulating and protecting electrical components. While they may have some industrial coatings, the vast majority of their revenue and strategic focus lies within electrical insulation, serving industries like power generation, transmission & distribution, automotive, and consumer durables. Specific revenue percentages for sub-segments are not publicly detailed, but electrical insulation is the dominant contributor.
Industry
Elantas Beck India operates in the specialty chemicals industry, specifically within the niche but critical sub-sector of electrical insulation materials. This industry is characterized by high technical expertise requirements, significant R&D investment, and stringent quality standards. The market is predominantly B2B, with long-standing customer relationships. Elantas Beck India holds a leading position in India for electrical insulation materials, benefiting significantly from the technological support, global R&D, and brand reputation of its parent company, ALTANA AG. It competes with other domestic and international players offering similar specialized chemical solutions.
MOAT
Technology & R&D: Access to ALTANA AG's global research and development capabilities, allowing for continuous innovation, product customization, and the development of high-performance, specialized solutions.
Customer Switching Costs: Their products are critical components in manufacturing processes (e.g., insulation for motors/transformers). Changing suppliers often involves rigorous testing, re-qualification, and potential production disruptions, making customers less likely to switch frequently.
Brand Reputation & Quality: Established reputation for reliability and quality in a sector where product failure can have significant consequences for customers.
Specialized Expertise: Deep domain knowledge and focused expertise in a niche segment of specialty chemicals, making it difficult for general chemical companies to compete effectively.
Growth Drivers
Infrastructure Development: Ongoing investments in power generation, transmission, and distribution in India will drive demand for transformers, motors, and other electrical equipment, increasing the need for insulation materials.
Automotive Sector Growth: Expansion in the automotive industry, particularly the accelerating adoption of electric vehicles (EVs), will create new demand for specialized insulation for EV motors and power electronics.
"Make in India" Initiative: Government push for domestic manufacturing across various sectors could boost demand for locally sourced specialty chemicals.
Urbanization & Industrialization: Increasing demand for consumer appliances, industrial machinery, and electronic goods contributes to the overall growth of the electrical and electronics sectors.
Exports: Potential to leverage the parent company's global network to expand exports.
Risks
Economic Downturn: The company's performance is linked to industrial activity; an economic slowdown in India or globally could impact demand for its products.
Raw Material Price Volatility: Reliance on crude oil derivatives and other commodity chemicals means raw material price fluctuations can significantly impact manufacturing costs and margins.
Technological Changes: Rapid advancements in electrical and electronics technology necessitate continuous R&D and adaptation; failure to keep pace could lead to product obsolescence.
Competition: Intense competition from both domestic and international specialty chemical manufacturers, potentially leading to pricing pressures.
Regulatory & Environmental Compliance: Evolving environmental norms and other industry regulations could lead to increased operational costs or require significant investments in compliance.
Management & Ownership
Elantas Beck India Ltd. is majority-owned by ALTANA AG, a German specialty chemicals group. This provides strong corporate governance, access to global best practices, and a clear strategic direction. The management team typically comprises experienced professionals with a strong focus on R&D, quality, and specialized applications, benefiting from the global parent's expertise and long-term vision in the specialty chemicals sector. The ownership structure ensures a strong promoter backing and technical collaboration.
Outlook
Elantas Beck India is well-positioned as a leader in the critical electrical insulation materials segment in India, supported by the technological prowess and global network of its parent, ALTANA AG. The company is poised to benefit from India's structural growth drivers such as infrastructure development, industrialization, and the rising demand for electric vehicles, which will drive demand for electrical components and, consequently, insulation materials. However, its performance remains susceptible to cyclical economic slowdowns and volatility in raw material prices. Sustained investment in R&D and maintaining its technological edge will be crucial to navigate competitive pressures and evolving industry standards. The company's established market position and strong parentage provide resilience, but it must continually innovate and manage operational costs effectively to ensure consistent growth.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 174 | 177 | 191 | 184 | 197 | 206 | 210 | 217 | 215 | 222 |
| Other Income | 17 | 15 | 17 | 12 | 10 | 9 | 18 | 7 | 14 | 3 |
| Total Income | 191 | 192 | 208 | 196 | 207 | 215 | 228 | 224 | 229 | 225 |
| Total Expenditure | 138 | 139 | 153 | 150 | 162 | 166 | 170 | 169 | 170 | 179 |
| Operating Profit | 52 | 53 | 56 | 46 | 45 | 49 | 58 | 54 | 59 | 46 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 3 | 3 | 3 | 4 | 5 | 5 | 5 | 6 | 6 | 6 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 49 | 49 | 52 | 42 | 40 | 44 | 53 | 49 | 53 | 40 |
| Provision for Tax | 12 | 13 | 11 | 11 | 10 | 11 | 14 | 12 | 13 | 9 |
| Profit After Tax | 37 | 37 | 42 | 31 | 30 | 33 | 39 | 36 | 39 | 31 |
| Adjustments | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 37 | 37 | 42 | 31 | 30 | 33 | 39 | 36 | 39 | 31 |
| Adjusted Earnings Per Share | 46.7 | 46.6 | 52.8 | 39.2 | 37.5 | 41.5 | 49.6 | 45.7 | 49.7 | 39.2 |
| #(Fig in Cr.) | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 344 | 365 | 383 | 409 | 394 | 383 | 522 | 645 | 680 | 749 | 848 | 864 |
| Other Income | 6 | 8 | 9 | 12 | 18 | 22 | 16 | 21 | 53 | 55 | 48 | 42 |
| Total Income | 350 | 373 | 391 | 421 | 412 | 405 | 538 | 666 | 733 | 803 | 896 | 906 |
| Total Expenditure | 282 | 287 | 304 | 344 | 340 | 313 | 444 | 535 | 537 | 604 | 676 | 688 |
| Operating Profit | 68 | 86 | 87 | 77 | 71 | 92 | 95 | 131 | 196 | 199 | 220 | 217 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 |
| Depreciation | 6 | 5 | 6 | 7 | 7 | 12 | 12 | 12 | 12 | 15 | 21 | 23 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 19 | 0 | 0 | 9 | 11 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 62 | 81 | 81 | 89 | 64 | 80 | 91 | 129 | 184 | 183 | 199 | 195 |
| Provision for Tax | 20 | 26 | 26 | 23 | 14 | 18 | 24 | 31 | 46 | 44 | 51 | 48 |
| Profit After Tax | 42 | 54 | 55 | 66 | 50 | 62 | 67 | 98 | 137 | 140 | 148 | 145 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 42 | 54 | 55 | 66 | 50 | 62 | 67 | 98 | 137 | 140 | 148 | 145 |
| Adjusted Earnings Per Share | 52.7 | 68.7 | 69.5 | 83 | 62.5 | 77.9 | 84.4 | 123.3 | 173.2 | 176 | 186.4 | 184.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 13% | 10% | 17% | 9% |
| Operating Profit CAGR | 11% | 19% | 19% | 12% |
| PAT CAGR | 6% | 15% | 19% | 13% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -9% | 15% | 21% | 20% |
| ROE Average | 16% | 18% | 17% | 19% |
| ROCE Average | 21% | 24% | 23% | 27% |
| #(Fig in Cr.) | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 172 | 222 | 278 | 339 | 384 | 442 | 505 | 599 | 732 | 867 | 1008 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 5 | 4 | 7 | 14 | 12 | 14 | 17 | 16 | 25 | 25 | 36 |
| Total Current Liabilities | 59 | 64 | 63 | 62 | 60 | 80 | 96 | 103 | 124 | 123 | 122 |
| Total Liabilities | 236 | 291 | 348 | 415 | 456 | 536 | 618 | 717 | 881 | 1015 | 1166 |
| Fixed Assets | 45 | 36 | 40 | 65 | 105 | 98 | 93 | 94 | 95 | 219 | 235 |
| Other Non-Current Assets | 4 | 8 | 20 | 27 | 43 | 66 | 68 | 37 | 27 | 26 | 19 |
| Total Current Assets | 187 | 246 | 283 | 323 | 308 | 373 | 457 | 587 | 759 | 771 | 913 |
| Total Assets | 236 | 291 | 348 | 415 | 456 | 536 | 618 | 717 | 881 | 1015 | 1166 |
| #(Fig in Cr.) | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 3 | 3 | 4 | 5 | 2 | 6 | 12 | 3 | 6 | 3 | 140 |
| Cash Flow from Operating Activities | 46 | 56 | 51 | 33 | 48 | 79 | 29 | 83 | 133 | 63 | 127 |
| Cash Flow from Investing Activities | -42 | -51 | -45 | -32 | -40 | -69 | -33 | -76 | -132 | 78 | -194 |
| Cash Flow from Financing Activities | -4 | -5 | -5 | -4 | -5 | -4 | -4 | -5 | -5 | -5 | -6 |
| Net Cash Inflow / Outflow | 0 | 0 | 2 | -3 | 4 | 6 | -8 | 2 | -3 | 136 | -74 |
| Closing Cash & Cash Equivalent | 3 | 4 | 5 | 2 | 6 | 12 | 3 | 6 | 3 | 140 | 66 |
| # | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 52.67 | 68.73 | 69.48 | 82.98 | 62.52 | 77.91 | 84.36 | 123.34 | 173.18 | 176.05 | 186.41 |
| CEPS(Rs) | 60.17 | 75.27 | 76.53 | 91.28 | 71.79 | 92.67 | 99.64 | 138.97 | 188.19 | 195.01 | 213.24 |
| DPS(Rs) | 5 | 4.5 | 4.5 | 4.5 | 5 | 5 | 5 | 5 | 5 | 7.5 | 7.5 |
| Book NAV/Share(Rs) | 216.59 | 279.89 | 350.2 | 427.63 | 484.41 | 557.03 | 636.59 | 755.07 | 923.34 | 1093.78 | 1271.75 |
| Core EBITDA Margin(%) | 16.11 | 19.19 | 19.28 | 15.83 | 13.66 | 18.36 | 14.99 | 17.09 | 21.05 | 19.29 | 20.31 |
| EBIT Margin(%) | 16.02 | 19.79 | 20.02 | 21.85 | 16.27 | 20.99 | 17.55 | 20.13 | 27.09 | 24.6 | 23.48 |
| Pre Tax Margin(%) | 15.97 | 19.74 | 19.97 | 21.79 | 16.19 | 20.94 | 17.5 | 20.03 | 27.01 | 24.51 | 23.42 |
| PAT Margin (%) | 10.81 | 13.3 | 13.57 | 16.08 | 12.58 | 16.12 | 12.81 | 15.17 | 20.19 | 18.65 | 17.43 |
| Cash Profit Margin (%) | 12.34 | 14.56 | 14.94 | 17.69 | 14.44 | 19.18 | 15.13 | 17.09 | 21.94 | 20.65 | 19.94 |
| ROA(%) | 19.51 | 20.71 | 17.26 | 17.24 | 11.37 | 12.44 | 11.58 | 14.64 | 17.18 | 14.72 | 13.55 |
| ROE(%) | 27.17 | 27.69 | 22.05 | 21.34 | 13.71 | 14.96 | 14.14 | 17.73 | 20.64 | 17.46 | 15.76 |
| ROCE(%) | 40.3 | 41.21 | 32.55 | 29 | 17.74 | 19.48 | 19.37 | 23.52 | 27.69 | 23.03 | 21.23 |
| Receivable days | 49.64 | 48.44 | 56.76 | 69.9 | 67 | 62.69 | 55 | 53.57 | 54.87 | 55.73 | 57.41 |
| Inventory Days | 48.26 | 47.59 | 45.44 | 42.83 | 46.73 | 48.8 | 47.75 | 46.36 | 41.09 | 41.03 | 41.35 |
| Payable days | 64.78 | 70.7 | 71.05 | 67.18 | 65.9 | 82.18 | 76.86 | 67.85 | 74.36 | 73.97 | 64.7 |
| PER(x) | 29.3 | 26.45 | 32.38 | 27.14 | 39.54 | 35.37 | 43.56 | 35.25 | 49.04 | 72.59 | 51.36 |
| Price/Book(x) | 7.13 | 6.5 | 6.42 | 5.27 | 5.1 | 4.95 | 5.77 | 5.76 | 9.2 | 11.68 | 7.53 |
| Dividend Yield(%) | 0.32 | 0.25 | 0.2 | 0.2 | 0.2 | 0.18 | 0.14 | 0.12 | 0.06 | 0.06 | 0.08 |
| EV/Net Sales(x) | 3.52 | 3.9 | 4.6 | 4.34 | 4.91 | 5.63 | 5.55 | 5.28 | 9.82 | 13.33 | 8.87 |
| EV/Core EBITDA(x) | 17.86 | 16.5 | 20.27 | 23.14 | 27.07 | 23.42 | 30.61 | 25.91 | 34.05 | 50.1 | 34.13 |
| Net Sales Growth(%) | 0.8 | 6.13 | 4.74 | 6.94 | -3.68 | -2.77 | 36.28 | 23.48 | 5.46 | 10.09 | 13.27 |
| EBIT Growth(%) | 36.97 | 30.97 | 0.25 | 9.96 | -28.27 | 25.43 | 13.92 | 41.61 | 41.96 | -0.05 | 8.12 |
| PAT Growth(%) | 32.11 | 30.49 | 1.09 | 19.43 | -24.66 | 24.62 | 8.29 | 46.2 | 40.41 | 1.65 | 5.89 |
| EPS Growth(%) | 32.11 | 30.49 | 1.09 | 19.43 | -24.66 | 24.62 | 8.29 | 46.2 | 40.41 | 1.65 | 5.89 |
| Debt/Equity(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio(x) | 3.15 | 3.82 | 4.49 | 5.23 | 5.11 | 4.65 | 4.75 | 5.69 | 6.12 | 6.26 | 7.47 |
| Quick Ratio(x) | 2.3 | 2.95 | 3.78 | 4.4 | 4.28 | 3.99 | 3.88 | 4.92 | 5.53 | 5.49 | 6.67 |
| Interest Cover(x) | 329.54 | 394.83 | 389.19 | 382.21 | 189.78 | 368.45 | 367.54 | 210.09 | 322.52 | 279.59 | 387.71 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
| FII | 0.71 | 0.7 | 0.67 | 0.67 | 0.67 | 0.51 | 0.04 | 0.04 | 0.04 | 0.04 |
| DII | 11.79 | 11.87 | 11.9 | 11.88 | 11.71 | 11.7 | 12.17 | 12.17 | 12.21 | 12.25 |
| Public | 12.5 | 12.43 | 12.42 | 12.44 | 12.62 | 12.79 | 12.79 | 12.79 | 12.75 | 12.71 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 |
| FII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.1 | 0.1 | 0.1 | 0.1 |
| Public | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.79 | 0.79 | 0.79 | 0.79 | 0.79 | 0.79 | 0.79 | 0.79 | 0.79 | 0.79 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +13% | +10% | +17% | +9% |
| Operating Profit CAGR | +11% | +19% | +19% | +12% |
| PAT CAGR | +6% | +15% | +19% | +13% |
| Share Price CAGR | -9% | +15% | +21% | +20% |
| ROE Average | +16% | +18% | +17% | +19% |
| ROCE Average | +21% | +24% | +23% | +27% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
| FII | 0.71 | 0.7 | 0.67 | 0.67 | 0.67 | 0.51 | 0.04 | 0.04 | 0.04 | 0.04 |
| DII | 11.79 | 11.87 | 11.9 | 11.88 | 11.71 | 11.7 | 12.17 | 12.17 | 12.21 | 12.25 |
| Public | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 |
| FII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.1 | 0.1 | 0.1 | 0.1 |
| Public | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.79 | 0.79 | 0.79 | 0.79 | 0.79 | 0.79 | 0.79 | 0.79 | 0.79 | 0.79 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.